Stammdaten
Scorpius Holdings Inc., through its subsidiary Scorpius BioManufacturing, operates as an integrated contract development and manufacturing organization. The company provides analytical testing, downstream process development, formulation optimization and development, and clinical biomanufacturing services to pharmaceutical and biotech companies. It is also involved in the provision of pre-clinical and product development; chemistry, manufacturing, and control analytical support; and bioassays. The company was formerly known as NightHawk Biosciences, Inc. and changed its name to Scorpius Holdings, Inc. in February 2024. Scorpius Holdings, Inc. was incorporated in 2008 and is based in Morrisville, North Carolina.
Unternehmen & Branche
| Name | Scorpius Holdings, Inc. |
|---|---|
| Ticker | SCPX |
| CIK | 0001476963 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Biotechnology |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 13.626 USD |
| Beta | -4,99 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-09-30 | 10-Q | -984,429 | -0.02 | 20,770,975 | -1,329,696 | |
| 2025-06-30 | 10-Q | -4,080,283 | -0.09 | 21,569,042 | -2,485,374 | |
| 2025-03-31 | 10-Q | -10,714,555 | -1.16 | 23,585,574 | -1,367,055 | |
| 2024-12-31 | 10-K | -32,807,843 | -13.04 | 39,177,719 | 6,299,620 | |
| 2024-09-30 | 10-Q | -10,114,144 | -1.43 | 46,534,593 | 28,727,131 | |
| 2024-06-30 | 10-Q | -8,874,848 | -26.98 | 46,687,847 | 25,611,753 | |
| 2024-03-31 | 10-Q | -4,417,549 | -31.38 | 50,502,108 | 28,599,815 | |
| 2023-12-31 | 10-K | -45,217,168 | -347.50 | 51,037,627 | 31,396,532 | |
| 2023-09-30 | 10-Q | -13,132,470 | -100.82 | 69,915,144 | 36,292,557 | |
| 2023-06-30 | 10-Q | -13,892,016 | -106.67 | 80,184,407 | 48,733,750 | |
| 2023-03-31 | 10-Q | -12,784,647 | -0.49 | 91,517,951 | 61,935,880 | |
| 2022-12-31 | 10-K | -43,434,706 | -1.70 | 104,396,912 | 73,922,847 | |
| 2022-09-30 | 10-K | -13,258,350 | -0.52 | 119,911,913 | 87,538,725 | |
| 2022-09-30 | 10-Q | -13,258,350 | -0.52 | 120,164,914 | 84,465,725 | |
| 2022-06-30 | 10-K | -6,831,286 | -0.27 | 99,964,241 | ||
| 2022-06-30 | 10-Q | -6,831,286 | -0.27 | 131,854,793 | 96,638,241 | |
| 2022-03-31 | 10-Q | -8,120,587 | -0.32 | 114,266,522 | 105,842,442 | |
| 2021-12-31 | 10-K | -35,071,468 | -1.41 | 120,961,233 | 113,108,314 | |
| 2021-09-30 | 10-Q | -7,432,720 | -0.30 | 132,655,225 | 124,894,690 | |
| 2021-06-30 | 10-Q | -6,543,197 | -0.26 | 138,789,519 | 131,386,088 |
Fondsaktivität (Vorquartalsvergleich)
Insider-Transaktionen (12 Monate)
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.